| Bioactivity | Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection[1][2]. |
| Invitro | Lenvervimab (1 nM-1 μM，16 小时) 抑制感染 HBV 的 HepG2-NTCP 细胞中的 HBV 感染[1]。Lenvervimab 可识别 HBV 感染的许多病毒基因型和临床变异体[1]。 Western Blot Analysis[1] Cell Line: |
| Name | Lenvervimab |
| CAS | 2055006-79-4 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jeong GU, et al. A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants. PLoS One. 2020 Aug 13;15(8):e0236704. [2]. Lee HW, et al. Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2020 Dec;18(13):3043-3045.e1. |